Evaluation of Eazyplex® LAMP test for fast Candida auris direct detection of colonized patients

Author:

Hernández Felices Francisco Javier1ORCID,Tormo Palop Nuria1ORCID,Salvador García Carme1ORCID,Mulet Bayona Juan Vicente1ORCID,Guna Serrano M. Remedio12ORCID,Gimeno Cardona Concepción12ORCID

Affiliation:

1. Department of Microbiology and Parasitology Consorcio Hospital General Universitario de Valencia Valencia Spain

2. Department of Microbiology and Ecology University of Valencia Valencia Spain

Abstract

AbstractCandida auris is a multidrug‐resistant pathogen yeast that produces nosocomial outbreaks, due to its ability in colonizing the skin, mucous membranes and surfaces. Rapid diagnosis is essential to control its spread. The aim of this study was to compare the Eazyplex® Candida auris kit (AmplexDiagnostics GmbH) for the rapid identification of patients colonized with C. auris, with the reference method used in our institution (culture and identification by MALDI‐TOF). This easy‐to‐perform test allows obtaining a fast result, in ~30 min. First, we achieved a preliminary study from previously characterized Candida species colonies obtained from 51 clinical samples, with 100% agreement between culture isolation and the Eazyplex® Candida auris LAMP. Second, 152 epidemiological surveillance samples (pharyngeal and axillary‐rectal swabs) were tested retrospectively. The sensitivity, specificity, positive and negative predictive values were 91.8%, 98.8%, 98.2% and 94.5%, respectively. Eazyplex® Candida auris showed acceptable results compared with culture in detecting C. auris from surveillance samples with the advantage of single‐test and shorter time for handling and result than culture, in addition to its great specificity, positive and negative predictive values.

Publisher

Wiley

Subject

Infectious Diseases,Dermatology,General Medicine

Reference22 articles.

1. Centers for Disease Control and Prevention. CDC.General information aboutCandida auris.https://www.cdc.gov/fungal/candida‐auris/candida‐auris‐qanda.html. Accessed July 20 2023

2. Candida aurissp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital

3. Centers for Disease Control and Prevention. CDC.TrackingCandida auris.https://www.cdc.gov/fungal/candida‐auris/tracking‐c‐auris.html. Accessed July 20 2023

4. Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004–2008

5. Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3